NDUFAB1 and allergic disease: As can be seen from the above information, a variety of ACP compounds act on IgE-related pathways, including Lyoniresinol, Limonin, etc. Some compounds also have specific anti-inflammatory effects, including nomilin, dillapiol, etc. Existing evidence shows that current anti-allergy drugs mainly act on specific targets like histamine receptors and leukotriene receptors, working by inhibiting histamine release, antagonizing histamine receptors, and suppressing inflammation [8].